Skip to Main Content Go to Sitemap

Search SickKids

SickKids researchers awarded $7.5 million for microbiome and immunology research

February 7, 2020

Researchers from SickKids recently received $7.5 million in funding to study the microbiome and immunology. These team grants were awarded by CIHR and partners in the Canadian Microbiome Initiative 2 and Human Immunology Initiative competitions.

Photo of exterior of Peter Gilgan Centre for Research and Learning

Going ‘outside the box’ to explain different symptoms in people with the same DNA deletion syndrome

November 9, 2020

Even when genetic conditions can be clearly traced to a root cause in the DNA, how those conditions present can vary. A team from the International 22q11.2 Deletion Syndrome Brain Behavior Consortium (IBBC), led by SickKids, discovered they needed …

Dr. Jacob Vorstman

Intermittent monitoring of stabilized bronchiolitis is best approach, SickKids-led study finds

March 3, 2021

A SickKids-led randomized clinical trial found intermittent pulse oximetry monitoring of infants with stabilized bronchiolitis is preferred to continuous pulse oximetry monitoring.

Read more about our bronchiolitis research

SickKids researchers ‘model’ future of precision medicine for rare inherited disorders

March 16, 2021

SickKids study shows promising proof-of-concept for an innovative CRISPR-Cas9 treatment strategy.

SickKids scientist Dr. Jean-Philippe Julien named one of Canada’s Top 40 Under 40

November 18, 2021

Dr. Jean-Philippe Julien is one of Canada’s Top 40 Under 40® for 2021, recognized for his contributions to antibody research and commitment to research translation.

SickKids study identifies potential predictor for developing cystic fibrosis for children with an inconclusive diagnosis

November 25, 2021

Researchers have identified for the first time a potential biomarker that could be used as a predictive tool in the care of children with CFSPID, an inconclusive cystic fibrosis diagnosis.

SickKids-led research uncovers potential immune-based therapy for difficult to treat childhood cancers

January 27, 2022

Immune checkpoint inhibitors may help treat some childhood cancers that are resistant to more common cancer treatments such as chemotherapy and radiation therapy.

Dr. Zulfiqar Bhutta receives prestigious Gairdner Foundation award for work in maternal-child health

April 5, 2022

Dr. Bhutta receives the John Dirks Canada Gairdner Global Health Award in recognition of global health research and interventions in the ‘first 1,000 days’ of life.

Innovation Showcase returns to highlight SickKids technologies and innovators

May 13, 2022

Annual commercialization event offers attendees access to emerging therapeutic and diagnostic SickKids technologies with high potential for market disruption and clinical impact.

SickKids Innovation Showcase

SickKids launching simulation study to assess impact of school-reopening health and safety measures

August 13, 2020

SickKids is leading a research study that will look at the effects of physical distancing, masking, hand hygiene and other health and safety measures for students and teachers returning to school during the COVID-19 pandemic.

Boy in a classroom with a backpack

Popular links

Back to Top